Riancorp

We are a company that focuses on medical laser products for photochemical applications in the field of Low Level Laser Therapy (LLLT). Our products are cost effective and appropriately designed for their intended purpose, and we support these products with honest clinical data and outstanding customer support. Certified by the Australian TGA, the FDA, the CE Mark and cleared by the Japanese Department of Agriculture, the RianCorp LTU-904 is a tried and tested, painless solution for the treatment of postmastectomy lymphoedema. This device is the ONLY laser device cleared by FDA for lymphedema treatment after breast cancer - backed with honest clinical data and outstanding customer support, it offers a range of benefits including dramatically shortened recovery time and improved quality of life. RianCorp has completed the first randomised double blind clinical trial testing the effects of LLLT on lymphoedema/lymphedema in the world. Being the only lymphoedema treatment trialled in such a study, it has proven results and works very effectively in about 30% of patients, and with some effect in about 50% of patients. LLLT is also effective in treating slow healing skin wounds, fibrous lesions, sprained and strained ligaments, tendon injuries, and muscle soreness. Using the non-invasive, patient friendly LTU-904, patients and clinicians alike can treat such conditions with relative ease both at home and in the clinic. The LTU-904 is available for hire or purchase by both patients and therapists. Find out more by visiting our website, www.riancorp.com, or by contacting us via email at [email protected] or phone 08 8232 8822 (AU), +61 8 8232 8822 (INTL).

• Employees 1
• Annual Revenue $22148000